Therapeutic area intelligence for Insulin Delivery with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

Insulet →

Recent signals(2)

RegulatoryAugust 16, 2026

Insulet's Omnipod Pods face early alert due to insulin leakage issue

Insulet's Omnipod Pods are currently under an early alert due to identified tears in the tubing, which may result in insulin leakage instead of proper delivery to patients.

StrategyJuly 3, 2026

Insulet Recalls Omnipod Pods Due to Insulin Leakage Risk

Insulet has recalled certain Omnipod Pods due to a defect that may cause insulin leakage.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Diabetes →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.